Zhao-Lei Zeng

7.9k total citations · 3 hit papers
90 papers, 4.9k citations indexed

About

Zhao-Lei Zeng is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhao-Lei Zeng has authored 90 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 44 papers in Cancer Research and 35 papers in Oncology. Recurrent topics in Zhao-Lei Zeng's work include Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (20 papers) and MicroRNA in disease regulation (11 papers). Zhao-Lei Zeng is often cited by papers focused on Cancer-related molecular mechanisms research (20 papers), RNA modifications and cancer (20 papers) and MicroRNA in disease regulation (11 papers). Zhao-Lei Zeng collaborates with scholars based in China, United States and Hong Kong. Zhao-Lei Zeng's co-authors include Rui‐Hua Xu, Huai‐Qiang Ju, Dong-liang Chen, Hui Luo, Peng Huang, De‐Shen Wang, Dan Xie, Qi-Nian Wu, Feng Wang and Yuhong Li and has published in prestigious journals such as Nature Communications, Molecular Cell and Gastroenterology.

In The Last Decade

Zhao-Lei Zeng

87 papers receiving 4.9k citations

Hit Papers

METTL3 facilitates tumor progression via an m6A-IGF2BP2-d... 2019 2026 2021 2023 2019 2019 2022 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. METTL3 facilitates tumor progression via an m6A-IGF2BP2-dependent mechanism in colorectal carcinoma
    2019 606 citations Ting Li, Qi-Nian Wu et al. Molecular Cancer profile →
  2. LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer
    2019 374 citations Yun Wang, Jia-Huan Lu et al. Molecular Cancer profile →
  3. Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response
    2022 167 citations Zhen Zhang, Zixian Wang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhao-Lei Zeng China 39 3.5k 2.6k 1.1k 611 407 90 4.9k
Weiyi Fang China 37 2.9k 0.8× 1.8k 0.7× 1.0k 1.0× 470 0.8× 319 0.8× 138 4.5k
Jing‐Ping Yun China 41 3.5k 1.0× 2.5k 1.0× 1.6k 1.5× 863 1.4× 645 1.6× 151 5.8k
Libero Santarpia Italy 37 3.3k 0.9× 2.2k 0.8× 1.8k 1.7× 773 1.3× 447 1.1× 89 5.4k
Pixu Liu China 23 3.1k 0.9× 731 0.3× 1.2k 1.1× 563 0.9× 452 1.1× 44 4.4k
Jianping Guo China 37 3.0k 0.9× 1.1k 0.4× 1.3k 1.2× 669 1.1× 689 1.7× 124 4.8k
Paweł Surowiak Poland 32 2.3k 0.6× 930 0.4× 1.3k 1.2× 622 1.0× 356 0.9× 97 3.7k
Manran Liu China 41 3.7k 1.0× 2.5k 0.9× 1.8k 1.6× 452 0.7× 510 1.3× 83 5.3k
Chih‐Yang Wang Taiwan 32 2.3k 0.6× 1.1k 0.4× 1.1k 1.0× 672 1.1× 408 1.0× 108 3.6k
Yu‐Shui Ma China 31 1.9k 0.5× 1.3k 0.5× 619 0.6× 339 0.6× 332 0.8× 117 3.0k
Rongcheng Luo China 35 2.4k 0.7× 1.3k 0.5× 1.1k 1.0× 686 1.1× 502 1.2× 207 4.2k

Countries citing papers authored by Zhao-Lei Zeng

Since Specialization
Citations

This map shows the geographic impact of Zhao-Lei Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao-Lei Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao-Lei Zeng more than expected).

Fields of papers citing papers by Zhao-Lei Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao-Lei Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao-Lei Zeng. The network helps show where Zhao-Lei Zeng may publish in the future.

Co-authorship network of co-authors of Zhao-Lei Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao-Lei Zeng. A scholar is included among the top collaborators of Zhao-Lei Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao-Lei Zeng. Zhao-Lei Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Chen, Wei, Haojie Chen, Xiao Zhang, et al.. (2025). Nuclear mitochondrial acetyl-CoA acetyltransferase 1 orchestrates natural killer cell-dependent antitumor immunity in colorectal cancer. Signal Transduction and Targeted Therapy. 10(1). 138–138. 1 indexed citations
3.
Li, Yuanfang, Yongqiang Zheng, Run‐Cong Nie, et al.. (2024). CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut. 74(3). 350–363. 42 indexed citations
4.
Wu, Qi‐Nian, Ze-Kun Liu, Ze-Kun Liu, et al.. (2024). HIPK3 maintains sensitivity to platinum drugs and prevents disease progression in gastric cancer. Cancer Letters. 584. 216643–216643. 7 indexed citations
5.
Tian, Tian, Yongqiang Zheng, Hai‐Yu Mo, et al.. (2023). The liver microenvironment orchestrates FGL1-mediated immune escape and progression of metastatic colorectal cancer. Nature Communications. 14(1). 6690–6690. 44 indexed citations
6.
7.
Luo, Xiaojing, Ming-Ming He, Jia Liu, et al.. (2022). LncRNA TMPO-AS1 promotes esophageal squamous cell carcinoma progression by forming biomolecular condensates with FUS and p300 to regulate TMPO transcription. Experimental & Molecular Medicine. 54(6). 834–847. 24 indexed citations
8.
Liu, Zexian, Zhao-Lei Zeng, Xiao-Jing Luo, et al.. (2022). The Macrophage-Associated LncRNA MALR Facilitates ILF3 Liquid–Liquid Phase Separation to Promote HIF1α Signaling in Esophageal Cancer. Cancer Research. 83(9). 1476–1489. 37 indexed citations
9.
Wu, Qi‐Nian, Xiao-Jing Luo, Jia Liu, et al.. (2021). MYC-Activated LncRNA MNX1-AS1 Promotes the Progression of Colorectal Cancer by Stabilizing YB1. Cancer Research. 81(10). 2636–2650. 59 indexed citations
10.
Deng, Jiewei, Yunyun Yang, Zhao-Lei Zeng, et al.. (2021). Discovery of Potential Lipid Biomarkers for Human Colorectal Cancer by In-Capillary Extraction Nanoelectrospray Ionization Mass Spectrometry. Analytical Chemistry. 93(38). 13089–13098. 18 indexed citations
11.
Zhang, Zhen, Hao‐Xiang Wu, Zixian Wang, et al.. (2021). EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers. BMC Medicine. 19(1). 26–26. 27 indexed citations
12.
Hu, Peishan, Ting Li, Jin‐Fei Lin, et al.. (2020). VDR–SOX2 signaling promotes colorectal cancer stemness and malignancy in an acidic microenvironment. Signal Transduction and Targeted Therapy. 5(1). 183–183. 46 indexed citations
13.
Wang, Yun, Jia-Huan Lu, Qi-Nian Wu, et al.. (2019). LncRNA LINRIS stabilizes IGF2BP2 and promotes the aerobic glycolysis in colorectal cancer. Molecular Cancer. 18(1). 174–174. 374 indexed citations breakdown →
14.
15.
Lu, Yun-Xin, Huai‐Qiang Ju, Zexian Liu, et al.. (2018). ME1 Regulates NADPH Homeostasis to Promote Gastric Cancer Growth and Metastasis. Cancer Research. 78(8). 1972–1985. 95 indexed citations
16.
Li, Yan, Li Fu, Yanru Qin, et al.. (2014). Increased Expression of EIF5A2, Via Hypoxia or Gene Amplification, Contributes to Metastasis and Angiogenesis of Esophageal Squamous Cell Carcinoma. Gastroenterology. 146(7). 1701–1713.e9. 96 indexed citations
17.
Zeng, Zhao-Lei, Hui Luo, Jing Yang, et al.. (2013). Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer. Clinical Cancer Research. 20(4). 1042–1052. 120 indexed citations
18.
Zeng, Zhao-Lei, Huan‐Xin Lin, Xiaohui Zhao, et al.. (2012). Overexpression of GOLPH3 Promotes Proliferation and Tumorigenicity in Breast Cancer via Suppression of the FOXO1 Transcription Factor. Clinical Cancer Research. 18(15). 4059–4069. 129 indexed citations
19.
Chen, Dong-liang, De‐Shen Wang, Wen-jing Wu, et al.. (2012). Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis. 34(4). 803–811. 94 indexed citations
20.
Qiu, Miao‐Zhen, Zhao-Lei Zeng, Hui Luo, et al.. (2012). Copper-transporting P-type adenosine triphosphatase (ATP7A) is associated with platinum-resistance in non-small cell lung cancer (NSCLC). Journal of Translational Medicine. 10(1). 21–21. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Weiyi Fang Breakdown of academic impact, for papers by Jing‐Ping Yun Breakdown of academic impact, for papers by Libero Santarpia Breakdown of academic impact, for papers by Pixu Liu Breakdown of academic impact, for papers by Jianping Guo Breakdown of academic impact, for papers by Paweł Surowiak Breakdown of academic impact, for papers by Manran Liu Breakdown of academic impact, for papers by Chih‐Yang Wang Breakdown of academic impact, for papers by Yu‐Shui Ma Breakdown of academic impact, for papers by Rongcheng Luo
Rankless by CCL
2026